Literature DB >> 9795797

Safety of tetanus vaccination in relapsing-remitting multiple sclerosis.

J De Keyser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9795797     DOI： 10.1007/BF02962261

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   7.455


× No keyword cloud information.
  8 in total

1.  INFECTION AND IMMUNIZATION IN MULTIPLE SCLEROSIS.

Authors:  W A SIBLEY; J M FOLEY
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

2.  A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis.

Authors:  A E Miller; L A Morgante; L Y Buchwald; S M Nutile; P K Coyle; L B Krupp; C A Doscher; F D Lublin; R L Knobler; F Trantas; L Kelley; C R Smith; N La Rocca; S Lopez
Journal:  Neurology       Date:  1997-02       Impact factor: 9.910

3.  Hazard of influenza vaccine in neurologic patients.

Authors:  J Rabin
Journal:  JAMA       Date:  1973-07-02       Impact factor: 56.272

4.  Postinfectious and postvaccinial encephalomyelitis.

Authors:  S Sriram; L Steinman
Journal:  Neurol Clin       Date:  1984-05       Impact factor: 3.806

5.  Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine.

Authors:  L Herroelen; J de Keyser; G Ebinger
Journal:  Lancet       Date:  1991-11-09       Impact factor: 79.321

6.  Multiple sclerosis and hepatitis B vaccination.

Authors:  J P Nadler
Journal:  Clin Infect Dis       Date:  1993-11       Impact factor: 9.079

7.  Multiple sclerosis and vaccination.

Authors:  H Miller; W Cendrowski; K Shapira
Journal:  Br Med J       Date:  1967-04-22

8.  Swine influenza virus vaccination in patients with multiple sclerosis.

Authors:  L W Myers; G W Ellison; M Lucia; S Novom; M Holevoet; D Madden; J Sever; G R Noble
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226
  8 in total
  3 in total

Review 1.  Vaccination against infection in patients with multiple sclerosis.

Authors:  Micha Loebermann; Alexander Winkelmann; Hans-Peter Hartung; Hartmut Hengel; Emil C Reisinger; Uwe K Zettl
Journal:  Nat Rev Neurol       Date:  2012-01-24       Impact factor: 42.937

Review 2.  [Vaccination and multiple sclerosis].

Authors:  M Löbermann; A Winkelmann; E C Reisinger; U K Zettl
Journal:  Nervenarzt       Date:  2010-02       Impact factor: 1.214

Review 3.  Vaccines in Multiple Sclerosis.

Authors:  Eric M L Williamson; Salim Chahin; Joseph R Berger
Journal:  Curr Neurol Neurosci Rep       Date:  2016-04       Impact factor: 5.081
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.